Skip to main content
NOVT
NASDAQ Manufacturing

Novanta Closes $1.2B Riverpoint Medical Acquisition, Adds $854.7M in Debt

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Scientific Instrument Stocks · Technology
Sentiment info
Positive
Importance info
8
Price
$142.5
Mkt Cap
$5.041B
52W Low
$98.27
52W High
$171.85
52W Position info
45% above low
Off High info
17% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

NOVT sits 45% above its 52-week low of $98.27.

Summary

Novanta closed its $1.2 billion acquisition of Riverpoint Medical, funded by $616 million in new debt and cash, with a $250 million milestone payment due by early 2027. The deal is expected to add $0.18–$0.25 to adjusted EPS in 2027 and double medical consumables revenue.


Key Events · M&A and Partnerships · NOVT

  • Acquisition Closed

    On July 23, 2026, the acquisition of Riverpoint Medical was finalized, with Novanta paying approximately $1.2 billion in cash and a $250 million milestone payment due by January 8, 2027.

  • Financing and Debt Impact

    The transaction was funded by $616 million in borrowings under Novanta's revolving credit and delayed draw term loan facilities, plus cash on hand. As of July 22, 2026, consolidated debt rose to $854.7 million.

  • EPS Accretion Guidance

    Management expects the acquisition to contribute $0.18 to $0.25 of adjusted EPS in 2027, the first full year after close, and to be immediately accretive to organic growth, adjusted gross margins, and adjusted EBITDA margins.

  • Strategic Transformation

    Riverpoint Medical doubles Novanta's recurring medical consumables revenue to roughly $300 million and increases medical end-market exposure to 60% of total revenue, unlocking a $2 billion incremental addressable market.


Analysis · NOVT · Manufacturing

The acquisition of Riverpoint Medical is now complete, with Novanta paying approximately $1.2 billion in cash and a $250 million milestone payment due by January 2027. Funding came from $616 million in new borrowings and cash on hand, lifting consolidated debt to $854.7 million. Management expects the deal to be immediately accretive to organic growth, margins, and cash flows, contributing $0.18–$0.25 to adjusted EPS in 2027. This transaction transforms Novanta's medical consumables revenue to roughly $300 million and increases medical end-market exposure to 60% of total revenue, but the significant debt load introduces integration and leverage risks.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NOVT was trading at $142.50 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $5B. The 52-week trading range was $98.27 to $171.85. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NOVT - Latest Insights

NOVT
Nov 09, 2026, 5:00 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $144.00
Real-time Price: $115.20 info
Change: -$28.80 (-20%) info
Market Cap: $4.343B info
NOVT
Nov 09, 2026, 4:50 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $146.00
Real-time Price: $115.20 info
Change: -$30.80 (-21%) info
Market Cap: $4.343B info
NOVT
Nov 09, 2026, 4:45 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $146.00
Real-time Price: $115.20 info
Change: -$30.80 (-21%) info
Market Cap: $4.343B info
NOVT
Oct 02, 2026, 4:30 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $149.27
Real-time Price: $115.20 info
Change: -$34.07 (-23%) info
Market Cap: $4.343B info
NOVT
Aug 05, 2026, 5:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $158.00
Real-time Price: $115.20 info
Change: -$42.80 (-27%) info
Market Cap: $4.343B info